Study Links Wegovy to Possible Increased Risk of Blood Clots According to a 2021 study titled Comprehensive analysis of the safety of semaglutide in type 2 diabetes: a meta-analysis of the SUSTAIN and PIONEER trials, semaglutide drugs may increase a persons risk of developing a type of blood clot, called a deep vein thrombosis (DVT), by 266%
The importance of ongoing consultations in your weight loss journey Dr Ruch Karunadasa MBBS Bsc MRCGP, Chief Medical Director at PrivateDoc, discusses the importance of the right support when on a weight loss journey and how PrivateDoc's service can support patients who want to lose weight
In 2023, there was a notable increase in the number of newspaper articles and social media posts discussing tirzepatide
If they dont, your healthcare provider can try to appeal the insurance companys decision
Determining the right maintenance dose will depend on how your body responds to the medication, your weight loss goals, and any side effects you experience
Obesity and Metabolic Syndrome GLP-1 receptor agonists are well-established tools in combating obesity